Wells Fargo’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.55M | Buy |
|
|||||
2025
Q1 | $2.36M | Buy |
|
|||||
2024
Q4 | $1.73M | Sell |
|
|||||
2024
Q3 | $3.1M | Buy |
|
|||||
2024
Q2 | $607K | Buy |
|
|||||
2024
Q1 | $596K | Buy |
|
|||||
2023
Q4 | $476K | Sell |
|
|||||
2023
Q3 | $1.44M | Sell |
|
|||||
2023
Q2 | $2.36M | Buy |
|
|||||
2023
Q1 | $2.24M | Buy |
|
|||||
2022
Q4 | $1.23M | Buy |
|
|||||
2022
Q3 | $640K | Buy |
|
|||||
2022
Q2 | $94K | Sell |
|
|||||
2022
Q1 | $2.94M | Sell |
|
|||||
2021
Q4 | $2.8M | Sell |
|
|||||
2021
Q3 | $4.03M | Sell |
|
|||||
2021
Q2 | $4.49M | Buy |
|
|||||
2021
Q1 | $562K | Sell |
|
|||||
2020
Q4 | $790K | Sell |
|
|||||
2020
Q3 | $902K | Buy |
|
|||||
2020
Q2 | $1.21M | Buy |
|
|||||
2020
Q1 | $869K | Sell |
|
|||||
2019
Q4 | $1.87M | Buy |
|
|||||
2019
Q3 | $2.38M | Buy |
|
|||||
2019
Q2 | $452K | Buy |
|
|||||
2019
Q1 | $338K | Sell |
|
|||||
2018
Q4 | $160K | Buy |
|
|||||
2018
Q3 | $163K | Buy |
|
|||||
2018
Q2 | $125K | Sell |
|
|||||
2018
Q1 | $102K | Buy |
|
|||||
2017
Q4 | $154K | Buy |
|
|||||
2017
Q3 | $74K | Buy |
|
|||||
2016
Q2 | – | Sell |
|
|||||
2016
Q1 | $30K | Buy |
|
|||||
2015
Q4 | $53K | Sell |
|
|||||
2015
Q3 | $65K | Buy |
|
|||||
2015
Q2 | $16K | Sell |
|
|||||
2015
Q1 | $164K | Sell |
|
|||||
2014
Q4 | $270K | Buy |
|